Hyzaar and Bricanyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hyzaar and Bricanyl. Common interactions include acute generalised exanthematous pustulosis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people who take Hyzaar and Bricanyl have. It is created by eHealthMe based on reports of 7 people who take Hyzaar and Bricanyl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 04, 2022

7 people who take Hyzaar and Bricanyl together, and have interactions are studied.


What is Hyzaar?

Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 15,953 Hyzaar users for its effectiveness, alternative drugs and more.

What is Bricanyl?

Bricanyl has active ingredients of terbutaline sulfate. It is often used in asthma. eHealthMe is studying from 5,149 Bricanyl users for its effectiveness, alternative drugs and more.

Number of Hyzaar and Bricanyl reports submitted per year:

Hyzaar and Bricanyl drug interactions.

Common Hyzaar and Bricanyl drug interactions by gender *:

female:

  1. Acute generalised exanthematous pustulosis
  2. Toxic skin eruption
  3. Thrombocythaemia
  4. Lymphopenia
  5. Pyrexia
  6. Rash maculo-papular
  7. Skin lesion

male:

  1. Diarrhoea
  2. Abdominal pain upper
  3. Hypersensitivity
  4. Hypoventilation
  5. Increased upper airway secretion
  6. Insomnia
  7. Lung disorder
  8. Nasal congestion
  9. Nasopharyngitis
  10. Oropharyngeal pain

Common Hyzaar and Bricanyl drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dehydration
  2. Diarrhoea
  3. Hypercalcaemia
  4. Hyperphosphataemia
  5. Hypokalaemia
  6. Malaise
  7. Renal failure acute
  8. Syncope

50-59:

n/a

60+:

  1. Acute generalised exanthematous pustulosis
  2. Toxic skin eruption
  3. Dyspnoea exertional
  4. Eye pruritus
  5. Hypersensitivity
  6. Hypoventilation
  7. Increased upper airway secretion
  8. Insomnia
  9. Lung disorder
  10. Nasal congestion

* Approximation only. Some reports may have incomplete information.

Do you take Hyzaar and Bricanyl?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Hyzaar and Bricanyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hyzaar interactions:

Browse all interactions between Hyzaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Bricanyl interactions:

Browse all interactions between Bricanyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; losartan potassium and terbutaline sulfate (the active ingredients of Hyzaar and Bricanyl, respectively), and Hyzaar and Bricanyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: